121 related articles for article (PubMed ID: 8818781)
1. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent Albunex. An analysis of its correlation with pressure and velocity.
Tiukinhoy S; Bhoopalam S; Winkelmann JW; Ammar K; Mangulabnan L; Reddy G; Fernandez A; Block R; Malhotra V; Feinstein S
Invest Radiol; 1996 Jul; 31(7):415-22. PubMed ID: 8818781
[TBL] [Abstract][Full Text] [Related]
2. Effects of left ventricular pressure on sonicated albumin microbubbles: evaluation using an isolated rabbit heart model.
Mor-Avi V; Shroff SG; Robinson KA; Ng AF; Cholley BP; Marcus RH; Lang RM
J Am Coll Cardiol; 1994 Dec; 24(7):1779-85. PubMed ID: 7963128
[TBL] [Abstract][Full Text] [Related]
3. Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro.
Ota T; Hillman ND; Craig D; Kisslo J; Smith PK
J Am Soc Echocardiogr; 1997; 10(1):31-40. PubMed ID: 9046491
[TBL] [Abstract][Full Text] [Related]
4. Effect of pressure on intracardiac backscatter from microbubbles.
Deng Y; Li C; Chang Q
J Tongji Med Univ; 2001; 21(3):246-8. PubMed ID: 12539591
[TBL] [Abstract][Full Text] [Related]
5. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
Leischik R; Beller KD; Erbel R
Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
[TBL] [Abstract][Full Text] [Related]
7. Optimizing albunex in the left ventricle: an analysis of the technical parameters of four ultrasound systems in canines and humans.
Block RJ; Brodsky L; Ostoic T; Fernandez A; Hickle P; Devries S; Bieniarz T; In M; Feinstein SB
J Am Soc Echocardiogr; 1996; 9(6):787-94. PubMed ID: 8943438
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular opacification after intravenous injection of Albunex. The effect of different administration procedures.
Sonne HS; Christensen PD; Muan B; Assentoft J; Haider T; Kristensen BO
Int J Card Imaging; 1995 Mar; 11(1):47-53. PubMed ID: 7730681
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic contrast agents and left ventricular contractility: evaluation using an isolated rabbit heart model.
Mor-Avi V; Shroff SG; Robinson KA; Cholley BP; Ng AF; Lang RM
J Am Soc Echocardiogr; 1996; 9(4):452-61. PubMed ID: 8827628
[TBL] [Abstract][Full Text] [Related]
10. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
Keller MW; Glasheen W; Kaul S
J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
[TBL] [Abstract][Full Text] [Related]
11. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex.
Gandhok NK; Block R; Ostoic T; Rawal M; Hickle P; Devries S; Feinstein SB
J Am Soc Echocardiogr; 1997; 10(1):25-30. PubMed ID: 9046490
[TBL] [Abstract][Full Text] [Related]
12. Effects of Albunex infusion on left ventricular inflow velocity in dogs.
Tomita M; Wada H; Tanaka R; Miwa Y; Kagawa K; Noda T; Nishigaki K; Hirakawa S; Fujiwara H
J Cardiol; 1997 May; 29(5):283-91. PubMed ID: 9174884
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
14. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
[TBL] [Abstract][Full Text] [Related]
15. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
[TBL] [Abstract][Full Text] [Related]
16. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
[TBL] [Abstract][Full Text] [Related]
17. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
[TBL] [Abstract][Full Text] [Related]
18. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose].
Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R
Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717
[TBL] [Abstract][Full Text] [Related]
19. Albumin microbubble adherence to human coronary endothelium: implications for assessment of endothelial function using myocardial contrast echocardiography.
Villanueva FS; Jankowski RJ; Manaugh C; Wagner WR
J Am Coll Cardiol; 1997 Sep; 30(3):689-93. PubMed ID: 9283527
[TBL] [Abstract][Full Text] [Related]
20. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
Bouakaz A; de Jong N; Cachard C; Jouini K
Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
